Alopecia, accompanied by skin dryness, is one of the distressing side effects often occurring in chemotherapytreated cancer patients. Little is known of the effects of chemotherapy on sebaceous glands, despite their importance in hair follicle homeostasis. This study investigates sebaceous gland morphology and the response of SZ95 sebaceous gland cell line to doxorubicin (DXR) treatment. The morphology of sebaceous glands during intraperitoneal DXR treatment was investigated by optical and electron microscopy in a 7-day-old rat model and further confirmed in an adult mouse model. Moreover, in vitro studies using the SZ95 sebaceous gland cell line were performed to assess the response of sebocytes to DXR in terms of cell proliferation, apoptosis, and necrosis. DXR treatment induced sebaceous gland regression and occasionally caused their complete disappearance. This observed damage and disappearance preceded DXR-induced hair loss. In vitro experiments using the SZ95 sebaceous gland cell line indicated that DXR treatment induced a differentiation process leading to premature sebocytes apoptosis. Owing to the importance of the sebaceous gland in hair follicle homeostasis, DXR-induced involution of this gland might be related to subsequent hair loss.
INTRODUCTION
Sebaceous glands are flask-shaped, lobulated structures made of packed, differentiated epithelial cells that often have a foamy appearance in sections because of the lipid-rich droplets that fill their cytoplasm. Small cells located at the periphery of the gland are the germinative cells that constantly replace differentiating sebocytes. These glands exhibit holocrine secretion which empties into the upper region of the hair follicle canal. This secretory product contains exfoliated and disintegrated sebocytes that form an oily or greasy product known as sebum, which was historically thought to only serve as a softening and waterproofing agent for the skin. Current knowledge now indicates that the functions of the sebaceous gland are more complex. The sebum is now known to play important roles in the threedimensional organization of skin surface lipids and the integrity of the skin barrier (Stewart and Downing, 1991; Pilgram et al., 2001; Fluhr et al., 2004) , protect the skin against oxidative stress (Thiele et al., 1999) , and protect keratinocytes against UVB irradiation (Marques et al., 2002) . Moreover, the sebum also exhibits innate antimicrobial activity (Ge et al., 2003; Wille and Kydonieus, 2003; Georgel et al., in press) . Similarly, sebocytes express both pro-and anti-inflammatory properties (Zouboulis et al., 1998; Böhm et al., 2002; Toyoda et al., 2002; Wró bel et al., 2003) , are able to utilize cholesterol as a substrate for complete steroidogenesis (Fritsch et al., 2001; Thiboutot et al., 2003) , present a regulatory program for neuropeptides (Zouboulis et al., 2002) , and selectively control the action of hormones and xenobiotics on the skin (Akamatsu et al., 1992; Tsukada et al., 2000) . The importance of both the sebaceous gland and sebum production in skin homeostasis is further evidenced by the numerous skin disorders associated with their aberrant activity, the most common of such disorders being acne (Zouboulis et al., 2003; Zouboulis, 2004) .
Normal development and function of the sebaceous gland also appears to be very important for correct hair development and cycling. The hair follicle is considered as a miniorgan living in the context of the ''pilo-sebaceous'' unit, which is composed of hair follicle, sebaceous gland, and pilo-erector muscle (Montagna and Parakkal, 1974) . Abnormal sebaceous gland function within this context has been clearly associated with hair loss in several animal models for alopecia (Gates and Karasek, 1965; Gates et al., 1969; Williams and Stenn, 1994; Stenn, 2001; Porter et al., 2002) .
The administration of chemotherapeutics to humans causes toxic side effects that also lead to hair loss. Such side effects are frequently reversible but they still pose serious problems from a psychological point of view (Batchelor, 2001) . Although patients often complain of dry skin accompanying hair loss, studies on chemotherapy-induced alopecia have to date been focused on the degeneration of the deeper, transient portion of the hair follicle, the quality of the hair, or on abnormalities in hair pigmentation (Paus et al., 1994; Cece et al., 1996; Slominski et al., 1996; Ohnemus et al., 2004; Sharov et al., 2004) . A comprehensive study of the chemotherapy-induced changes within the upper portion of the pilo-sebaceous unit, in particular the sebaceous gland, is still lacking.
We have thus evaluated the effect of doxorubicin (DXR) treatment on the sebaceous gland in two different animal models: a neonatal rat and an adult mouse, both previously described for DXR-induced hair loss (Hussein et al., 1990; Selleri et al., 2005) . Regression of the sebaceous gland, occasionally including its complete disappearance, was observed in both models. Changes within the sebaceous gland were found to precede DXR-induced hair loss. Subsequent in vitro experiments, using the SZ95 sebaceous gland cell line (Zouboulis et al., 1999) , highlighted the sensitivity of sebocytes to DXR, which induced differentiation and premature apoptosis.
RESULTS

Morphological modifications of sebaceous glands induced by DXR treatment
In order to study the fate of the sebaceous gland during chemotherapy-induced alopecia, we investigated both the structure and ultrastructure of the sebaceous gland during DXR treatment in a newborn rat model and the structure of the sebaceous gland in an adult mouse model after DXR treatment. The degeneration of the sebaceous gland in both animal models was compared to time-matched control samples. In control samples, the gland maintained its morphological features, irrespective of time point of analysis ( Figure 1) .
In untreated control 7-day-old rats, optical microscopy showed sebaceous glands with normal morphology and functionality, evidenced by the presence of numerous secretory vesicles in the cytoplasm and by a positive staining for alkaline phosphatase (Figure 2a and b) . The cells appeared very metabolically active, with interspersed chromatin in the nucleus, detected by electron microscopy (Figure 3a) , which indicated transcriptional activity. Their cytoplasm was full of secretory vesicles of varying sizes, according to their state of maturation. Numerous mitochondria, endoplasmic reticulum, and free ribosomes were also all clearly visible. Lipid studies using Red Oil staining were performed at different time points. This staining a b c revealed that the sebocytes of control samples ( Figure 4a ) were filled with small lipid droplets, indicating normal glandular activity.
Five days after the start of DXR treatment, the sebaceous glands were strongly reduced in size (Figure 2c and d) and the cytoplasm of sebocytes appeared depleted of secretory granules (Figure 3b) . Apparently, under a conventional light microscopy, the hair follicles failed to show any significant signs of suffering. However, an increase in the number of apoptotic cells in the connective tissue sheath (CTS) and sporadically in the matrix cells was observed by highresolution light microscopy and by electron microscopy (data not shown), thus confirming previous observations (Selleri et al., 2004) . After 7 days, an almost complete regression of the sebaceous glands was observed in treated animals. At this stage, visible by optical microscopy and alkaline phosphatase staining, a significantly reduced number of cells were filled with excretory granules and a condensation of the cytoplasm was visible in the majority of sebocytes, (Figure 2e and f). Red Oil staining performed on these samples showed a reduction in intensity with respect to the control, demonstrating a reduced amount of lipid within the sebocytes (Figure 4b and c) . Electron microscopy revealed that these cells, which were reduced in size, showed an abnormally enlarged rough endoplasmic reticulum and much smaller vesicles. Mitochondria were conserved, thus suggesting that the sebocytes had not completely lost their metabolic function. An abnormal accumulation of collagen fibers was also noted among treated sebocytes (Figure 3c ). In the hair follicle, the initial phases of follicular structure degeneration, the first signs of oncosis in ORS cells, and apoptosis in CTS fibroblasts were now all detected (data not shown), as also previously reported (Selleri et al., 2004) .
Ten days after the start of DXR treatment, the regression of sebaceous glands was visible by optical microscopy. The almost complete disappearance of the sebaceous glands was further evidenced by alkaline phosphatase staining (Figure 2g was the only object present in the follicular canal ( Figure 3d ). In parallel, hair degeneration was almost complete, and treated animals started to show baldness within the occipital region.
To quantify rat sebaceous gland regression, sebaceous gland areas were measured at the different time points of observation. Value means are presented in Figure 5 . A dramatic reduction of gland surface area, starting from 5 days after the start of DXR treatment, was observed. The surface of the gland was almost completely undetectable 10 days after DXR treatment.
TUNEL assays on samples derived from both treated and control rats, killed at 5 and 7 days after DXR treatment, were performed in order to assess whether the reduction of sebaceous gland size was related to sebocyte apoptosis. Immunofluorescence analysis of untreated control animals indicated that 25 and 28% of sebocytes, at days 5 and 7 respectively, were apoptotic. These values are consistent with the physiological amount of sebocytes undergoing holocrine secretion. In contrast, a statistically significant (Po0.0001) increase in apoptosis was observed in the sebocytes of DXRtreated animals. In these DXR-treated animals, 47 and 66% of sebocytes were apoptotic, at days 5 and 7, respectively ( Figure 6 ).
We further evaluated the involution of the sebaceous gland using the adult mouse model. Analyses were performed 7 days after DXR treatment, when DXR-induced alopecia was evident. As previously observed in the newborn rat animal model, significant reductions of the sebaceous glands were clearly visible (Figure 7a and b) . Statistical analysis of the sebaceous gland surface area of treated and untreated animals again confirmed the data previously observed in the newborn rat model (Figure 7c) .
Evaluation of sebaceous gland morphology and size in untreated animals in the anagen and catagen stage revealed no difference among their glands, which always presented the same features during the hair cycle, in both the rat and the mouse model (Figure 8 ). 3 days 5 days 6 days *** *** *** * *** *** *** *** ** *** *** Figure 11 . Proliferation of SZ95 sebocyte cultures treated with different DXR concentrations. DXR concentrations greater than 10 À6 M were 100% toxic after only 2 days of treatment. In contrast, a DXR dose of 10 À7 M was subtoxic and dependent on the duration of treatment. *Po0.05, **Po0.01, ***Po0.001.
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DXR effect on SZ95 sebaceous gland cells
Terminal sebocyte differentiation, consisting of an increased cell volume, the accumulation of lipid droplets within the cytoplasm and nuclear degradation, has previously been shown to precede the physiological bursting of the cells and subsequent SZ95 cell death (Zouboulis et al., 1994) . However, premature sebocyte differentiation and apoptosis has also been described in SZ95 sebocytes treated with staurosporine, in which the sebocytes proceed to apoptosis without entering terminal differentiation marked by enhanced lipid synthesis (Wró bel et al., 2003) . Treatment of SZ95 sebocytes with different concentrations of DXR induced a dose-dependent increase of cytoplasm volume, which was first visible at a DXR concentration of 10 À7 M. This increase in cytoplasmic volume, indicating sebocyte differentiation (Figure 9 ), preceded the reduction of SZ95 sebocyte numbers (observed at a DXR concentration of 10 À6 M; Figure 10a ). Treatment with 10 À7 M DXR induced a time-dependent inhibition of SZ95 sebocyte proliferation, assessed by the 4-methylumbelliferyl heptanoate fluorescence assay. Only 10-fold increase in DXR (10 À6 M) caused a 100% inhibition of cell growth after 96 hours incubation (Figure 11) . At both the high, yet non-toxic (10 À7 M) and toxic (10 À6 M) DXR concentrations, a significant enhancement of caspase-3/7 activity was detected (Figure 10b) , indicating an enhanced rate of sebocyte apoptosis. However, nontoxic concentrations of DXR (10 À7 M) unessentially affected lipid synthesis, shortly before reaching the cytotoxic concentration (data not shown). This indicated that the observed increase in apoptosis was occurring prematurely, that is, before sebocytes entered terminal differentiation with increased lipid synthesis.
As shown in Figure 12 , TUNEL assay on SZ95 sebocyte cell line confirmed the data on apoptosis previously detected by caspase activity: whereas control cells (Figure 12a) show no positivity for TUNEL assay, the percentage of positive sebocytes increases with increasing DXR concentrations (Figure 12b and c) , so that at DXR 10 À5 M most of the cells are apoptotic (Figure 12d ). The graph and the table (Figure  12e ) clearly show these results.
At a 10 À6 M dose of DXR, cells began to both spontaneously detach from the culture dish and lose their flat epithelial morphology (Figure 9 ). At DXR concentrations above 2 Â 10 À6 M, a significant increase in lactate dehydrogenase was measured, indicating sebocyte necrosis ( Figure  10c ).
By considering DXR at a concentration of 10 À6 M as the critical dose over which major toxic effects were observed, we examined whether the inhibition of cell growth was due to cell cycle arrest. We analyzed the cell cycle at this dose of DXR by assessing the distribution of cellular DNA content by flow cytometry. A decreased G0-G1 peak, together with an accumulation of SZ95 sebocytes at the G2-M and S phases, was detected ( Figure 13 ). This phenomenon is known to precede apoptosis (Wróbel et al., 2003) . 
DISCUSSION
We observed the complete disruption of the sebaceous glands, preceding hair loss, in our animal models of chemotherapy-induced alopecia. This phenomenon appeared to accompany baldness, with a progressive and rapid reduction in the number and volume of lipid droplets within sebocytes and in a condensation of holocrine lipid secretion in the follicular canal. Five days after starting DXR treatment, sebaceous glands were still present, yet indicated a slow cell death which was incompatible with necrosis. Accordingly, data obtained by the TUNEL assay indicated a 50% increase in sebocyte apoptosis in DXR-treated animals with respect to the physiological level of apoptosis detected in control samples.
As holocrine secretion can be considered a form of apoptosis, it is quite usual to observe relatively high physiological levels of apoptosis within the sebaceous gland. The further increased levels of apoptosis observed in DXRtreated animals cannot be considered linked to increases in sebum production, but rather, must be associated with nonphysiological increases in sebocyte cell death. This was clearly demonstrated by Red Oil staining, which revealed the presence of lipids that only showed a faint staining in DXRtreated samples with respect to the control. This suggested that holocrine secretion of the sebaceous gland is reduced after DXR treatment, whereas apoptosis, leading to the sebocyte death, is increased.
As DXR induces premature catagen, we also evaluated the morphology and size of sebaceous glands during normal hair cycle, to exclude that the observed reduction in size of the gland was usually present during the spontaneous degeneration stage (catagen). Our data, in both the rat and the mouse model, indicate that during normal hair cycle, from anagen to catagen stage, the sebaceous gland does not show any reduction in size and maintains the same morphological features, as previously described (Han et al., 2005) .
We also performed in vitro studies on the SZ95 sebocyte cell line. This cell line is a widely used immortalized human sebaceous gland cell line, which retains the major characteristics of normal human sebocytes, such as differentiation with increases in both cell volume and lipid synthesis followed by apoptosis. These cells also express characteristic origin-and function-specific proteins of human sebaceous glands and respond correctly to androgens and retinoids (Zouboulis et al., 1999; Wró bel et al., 2003) .
Following the DXR treatment of SZ95 sebocytes, increases in both caspase activity and TUNEL positivity and cells within the G2-M and S phases of the cell cycle were observed. This finding indicated that apoptosis preceded physiological cell bursting and release of secretory granules (Wró bel et al., 2003) . Induction of apoptosis is a known typical effect of many anticancer drugs (Kim et al., 2002; Kaufmann and Vaux, 2003) . On the other hand, sebocytes in vivo undergo apoptosis after terminal differentiation and during holocrine secretion (Tamada et al., 1994; Kishimoto et al., 1999) . We can thus consider that, as already shown for staurosporine (Wró bel et al., 2003) , DXR accelerates this process by inducing apoptosis before sebocytes enter the terminal differentiation process. This is confirmed by the observed accumulation of sebum in the pilary canal, up to the level that sustains the regeneration of the sebaceous gland from its germinative layer. Considering the role of the sebaceous gland in hair follicle homeostasis, the direct action of DXR on the sebaceous gland can be associated with the occurring alopecia.
It is noteworthy that gland degeneration precedes hair loss. The involution of the sebaceous gland is significant at 5 days after DXR treatment. In contrast, only some rare apoptotic phenomena are present within the hair follicle at this time point, which starts to visibly degenerate only at day 7 after DXR treatment.
Lipid secretion from sebaceous glands seems to be involved in the correct protrusion of the hair shaft, by permitting the dissociation of the fiber from the inner root sheath. Previous in vitro studies have shown that in follicles deprived of their sebaceous gland portion, the shaft grows out with the inner root sheath. The mutant ''asebia'' mouse exhibits hair loss and scarring alopecia associated with markedly hypoplastic sebaceous glands (Stenn, 2001) . Data reported on this animal model indicate that the absence of sebaceous gland function leads to follicle destruction. Also the mutant ''defolliculated'' mouse shows abnormal differentiation of the sebaceous gland, with the sebocytes producing little or no sebum and undergoing abnormal cornification that accompanies an irregular hair follicle formation (Porter et al., 2002) .
To our knowledge, this is the first report of sebaceous gland damage during chemotherapy-induced alopecia.
Degeneration of the sebaceous gland after DXR treatment was observed in both newborn rats and in adult mice. This indicates that the observed degeneration is not restricted to a single animal model. It may be possible that this strong sebaceous gland degeneration, which was not observed in cyclofosfamide-induced alopecia (Ohnemus et al., 2004; Sharov et al., 2004) , is specifically related to DXR treatment. Damage to the sebaceous gland can explain the ''dry skin'' complaints frequently submitted by patients undergoing anticancer therapy. Considering the importance of the sebaceous gland in allowing correct hair cycle progression, our findings suggest the possible involvement of the sebaceous gland in chemotherapy-induced hair loss. Pharmacological studies targeting the prevention of premature apoptosis and sebaceous gland damage may be proven useful in controlling hair loss and skin xerosis in DXR-treated patients suffering from alopecia.
MATERIALS AND METHODS
In vivo experiments
Animals. For the rat model of chemotherapy-induced alopecia, we adopted the method described by Hussein et al. (1990) with only a few modifications: DXR 3 mg/kg/day for 4 subsequent days was injected intraperitoneally into 7-day-old rats with hair follicles in the final stages of postnatal hair follicle morphogenesis. Mild or severe alopecia, within the region of the head and neck, was observed in approximately 80% of the injected rats at about 10 days after the start of DXR administration. Skin samples were obtained daily during www.jidonline.org 7 S Selleri et al.
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DXR treatment from three treated and one control rat until alopecia was detected. For studies on adult mice, we adopted the method by Selleri et al. (2005) . The dorsal skin of 7-week-old C57BL/6 mice was treated with a mixture of wax-rosin. The removal of this mixture allowed for the complete removal of all the hair shafts. The homogeneous pink color of the skin revealed the telogen phase of the hairs. Depilation at this hair stage induced the development of a synchronous anagen stage. Mice received a single intraperitoneal dose of DXR (15 mg/kg) 9 days after depilation when synchronized hair follicles were in the anagen VI phase. Normal regrowth of hairs was observed in untreated control animals while the newly formed pelage was lost in DXR-treated animals. Skin samples were collected 7 days after DXR treatment, when the fur of untreated control animals had completely regrown and alopecia was clearly evident in DXRtreated mice.
For both the rat and the mouse model, we also collected samples from untreated animals in the anagen stage and in the spontaneous degeneration stage (catagen), to observe whether any change in sebaceous gland morphology was present.
Experimental protocols were approved by the Ethics Committee for Animal Experimentation of the Istituto Nazionale Tumori of Milan, according to guidelines of United Kingdom Co-ordinating Committee on Cancer Research for animal welfare in experimental neoplasia (1998).
Optical microscopy. Rat skin samples were snap frozen in liquid N 2 vapor immediately after the performance of the biopsy and included in OCT mounting medium. Cryostat sections (7 mm thickness) were obtained and stored at À301C until use.
C57BL/6 mice skin samples were collected from the back of mice and immediately fixed in 10% buffered formalin for 4 hours at 41C and embedded in paraffin. Paraffin specimens were sectioned at 5 mm and collected on silanized slides, deparaffinized, rehydrated, stained with hematoxylin and eosin and mounted in Entellan s .
Electron microscopy. Rat skin samples (2 Â 4 mm) were fixed in 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 3 hours at 41C, washed in 0.1 M phosphate buffer, postfixed in 1% osmium tetroxide in 0.1 M phosphate buffer, dehydrated through an ascending series of ethanol and embedded in araldite. Ultrathin sections were cut on a diamond knife, with a Reichter Ultracut R ultramicrotome (Leica, Wien, Austria), stained with uranyl acetate and lead citrate, and then observed with a Jeol CX100 transmission electron microscope (Jeol, Tokyo, Japan). Semithin sections were stained with toluidine blue for observation with optical microscope.
Red Oil staining. Cryostat sections of rat skin (7 mm thickness) were obtained and stored at À301C until use. At the moment of use, sections were washed in distilled water and stained for 10 minutes in Red Oil O solution (saturated solution of Red Oil in isopropylic alcohol). After washing in distilled water, slides were counterstained with hematoxylin to obtain nuclear staining, washed again in water, and mounted in glycerinated gelatin.
Alkaline phosphatase staining. Specific staining was performed on cryostat sections of rat skin using the BCIP/NBT liquid substrate system (Sigma, Deisenhofen, Germany). Briefly, sections were dried at room temperature, fixed with cold acetone (À301C) for 3 minutes, washed with physiological solution, incubated with the reagent (1-2 minutes) at room temperature in the dark, washed with bidistilled water and mounted with Mowiol (Calbiochem, Bad Soden, Germany). Cryostat sections stained for alkaline phosphatase activity, sections stained with Red Oil, and semithin sections stained with toluidine blue were all observed with a Nikon Eclipse 600 microscope equipped with a digital Nikon DXM 1200 camera.
Detection of apoptosis. DNA fragmentation was assessed by TUNEL (In situ cell detection kit; Roche Diagnostic GmbH, Penzberg, Germany), according to the manufacturer's instructions. Briefly, cryostat sections of rat skin were dried at room temperature, fixed for 20 minutes with 4% paraformaldehyde in phosphatebuffered saline (PBS) (pH 7.4) and washed in PBS. After a 10-minute incubation in blocking solution (3% H 2 O 2 in methanol), slides were rinsed with PBS and subsequently incubated for 2 minutes on ice in a permeabilization solution (0.1% Triton X-100, 0.1% sodium citrate). After rinsing with PBS, sections were incubated for 1 hour at 371C with the TUNEL Reaction Mixture (fluoresceinate), washed with PBS and mounted with Mowiol after the nuclei had been labelled with 4,6-diamidino-2-phenylindole staining.
Slides were analyzed by fluorescence microscopy using a Nikon Eclipse 600 equipped with selective excitation filters suitable for analyzing fluorescein labelled fragmented DNA and the 4,6-diamidino-2-phenylindole counterstain. Three independent observers randomly selected different optical fields containing sebaceous glands in order to determine the percentage of positive staining (apoptotic sebocytes).
Light microscopy morphometric analysis of the sebaceous glands. We considered about 40 pilo-sebaceous units from treated and untreated animals, from both rats and mice, at different time points. The sebaceous gland section area, from longitudinally sectioned hair follicles, was measured. Digital images of the samples were imported into the LaserPix image analysis program (version 4.0, Bio-Rad Laboratories (Segrate, Italy), sebaceous glands were manually outlined and section areas automatically measured. The software was previously calibrated using a micrometer object photographed at the same enlargement used to collect the images of the sebaceous glands.
In vitro experiments
Cell culture. SZ95 sebocytes (Zouboulis et al., 1999) , from passage 26, were maintained in Sebomed s culture medium (Biochrom, Berlin, Germany) supplemented with 10% fetal calf serum, 5 ng/ml human epidermal growth factor, 1 mM CaCl 2 , and 50 mg/ml gentamicin (all from Sigma), in a humidified atmosphere containing 5% CO 2 at 371C. Subconfluent cell cultures were harvested with Accutase (PAA, Cö lbe, Germany) and seeded in 96-well culture plates at a density of 2 Â 10 4 cells/well (approximately 60% confluence) in complete culture medium. All evaluations were performed 24 hours after seeding, in which cultures ranged between 80 and 100% confluence. Experiments were performed in triplicate, with 10 wells evaluated for each data point in each experiment.
DXR treatment. DXR was dissolved in dimethyl sulfoxide (Sigma) to give final concentrations between 10 À9 and 10 À5 M. The final concentration of dimethyl sulfoxide in the medium, either with or without DXR, was 0.1%.
Cell number assessment. Cell numbers were measured indirectly by the fluorescein diacetate assay (Sigma) as previously described (Larsson and Nygren, 1989) . Briefly, cells were stained with the fluorescent dye fluorescein diacetate. Fluorescence is dependent on cellular hydrolysis of the non-fluorescent substrate into its fluorescent product. Fluorescence signals from the two dyes were compared to give the amount of intact and viable cells in the culture.
Cell proliferation. Adherent SZ95 sebocytes (1,000 cells/well in 96-well plates) were washed with PBS and treated with DXR at the above-mentioned concentrations. Cell proliferation was assessed by the 4-methylumbelliferyl heptanoate assay and measured automatically, after 48 and 96 hours, as previously described (Zouboulis et al., 1991) . Culture medium was renewed on the second day of growth. Briefly, on the day of proliferation evaluation, the medium was removed, the cells were washed twice in PBS and 100 ml of a 100 mg/ml 4-methylumbelliferyl heptanoate fluorescence solution in PBS was added to each well. The plates were subsequently incubated at 371C for 30 minutes. The released fluorescence, representative for cell number, was read in a Molecular Devices SPECTRAmax Gemini spectrofluometer using 355 nm excitation and 460 nm emission filters.
Detection of apoptosis. Caspase-3/7 activity, as a measure of cell apoptosis, was analyzed using a high throughput screening commercial assay (Apo-ONE Homogenous Caspase-3/7 Assay, Promega, Madison, WI) according to the manufacturer's instructions. Briefly, upon cleavage on the C-terminal side of the aspartate residue in the DEVD peptide substrate sequence by caspase-3/7 enzymes, the rhodamine 110 becomes fluorescent. After DXR treatment of cells for 24 hours and incubation at 371C for 2 hours, the bifunctional cell lysis/activity buffer and the profluorescent caspase-3/7 consensus substrate bis-(N-CBZ-L-aspartyl-L-glutamyl-L-valyl-aspartic acid amide) rhodamine 110 (Z-DEVD-R110) provided were added to the cells. The solution was then excited at a wavelength of 498 nm and read at the maximum emission of 521 nm in a Molecular Devices SPECTRA Max Gemini spectrofluorometer. The amount of fluorescent product generated was representative of the amount of active caspase-3/7 present in the sample. Sebocytes apoptosis was confirmed performing TUNEL assay (DeadEnd Colorimetric TUNEL System, Promega Corporation, Madison, WI) on cells treated with the above-mentioned DXR concentrations for 24 hours, according to the manufacturer's instructions.
Detection of cell necrosis. Cell necrosis was determined using a colorimetric assay for the quantification of cell death and cell lysis (Cytotoxicity detection kit; Boehringer-Mannheim, Mannheim, Germany). This assay, as previously described (Wró bel et al., 2003) , is based on the release of lactate dehydrogenase from the cytoplasm of damaged cells into the supernatant.
Determination of cellular and nuclear size. Cellular and nuclear size of SZ95 sebocyte suspensions, harvested after cell dissociation with Accutase, was determined with the help of a cell counter with adequate software (Casy 1; Schärfe Systems, Reutlingen, Germany).
Cell cycle analysis. Cell cycle analysis was performed by twocolor FACS on a Becton-Dickinson (Heidelberg, Germany) flow cytometer, FACS-Calibur. SZ95 sebocytes (5 Â 10 5 ) were dissociated from culture dishes with Accutase, pelleted and resuspended in 400 ml citrate buffer in order to denature DNA. The cells were subsequently labelled as previously described (Dolbeare et al., 1983) , with BrdU, binding single-stranded DNA and propidium iodide, which binds intact DNA. The BrdU was detected using a fluorescein-conjugated BrdU antibody. Both fluoresceins were exited at 488 nm with an argon laser. The fluorescein emission of BrdU fluorescein was detected at 530 nm, whereas that of propidium iodide was detected at 585 nm. Overlapping emissions were electronically compensated. Data were evaluated, with respect to a nonspecific isotypic-matched antibody control, using CELLQuest software (Becton-Dickinson).
Presentation of the data and statistical analysis. All data are presented as mean values7standard deviation. Three or more repeats were performed for each assay. Statistical significance of the data was evaluated by the two-tailed Student's t-test. Mean differences were considered to be significant at Po0.05.
